Bristol-Myers Squibb
BMY
BMY
2,460 hedge funds and large institutions have $116B invested in Bristol-Myers Squibb in 2022 Q3 according to their latest regulatory filings, with 98 funds opening new positions, 987 increasing their positions, 1,016 reducing their positions, and 133 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $126B → $116B (-$9.68B)
14% less funds holding in top 10
Funds holding in top 10: 132 → 113 (-19)
26% less first-time investments, than exits
New positions opened: 98 | Existing positions closed: 133
Holders
2,460
Holding in Top 10
113
Calls
$1.98B
Puts
$1.57B
Top Buyers
| 1 | +$1.02B | |
| 2 | +$572M | |
| 3 | +$368M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$259M |
| 5 |
BlackRock
New York
|
+$239M |
Top Sellers
| 1 | -$604M | |
| 2 | -$469M | |
| 3 | -$281M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$240M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$197M |